Ona Therapeutics
- Health & Biotech
- Barcelona, ES
- Private
- ona-therapeutics.com
Barcelona biotech developing antibody-drug conjugates (ADCs) for hard-to-treat cancers, moving its lead asset into clinical development.
$86.6MEquity raised in 2025–20262025 — · 2026 $86.6M · 1 equity round
$86.6MEquity raised, all time1 equity round sourced so far
—Latest valuationnot disclosed
Rounds over time log-scaled amounts
Funding history 1 round · 1 source
Earlier rounds not yet sourced. Ona Therapeutics raised before 4 Jun 2026; only the rounds below are sourced so far, so its all-time equity total understates its history.
- Series BAmount$86.6MPost-money—✓ Confirmed
- Earlier rounds not yet sourced
Investors 10
- Columbus Venture Partners1
- Mérieux Equity Partners1
- Alta Life Sciences
- Asabys Partners
- Bpifrance
- CDTI
- COFIDES
- FundPlus NV
- Korys
- Ysios Capital
Highlighted investors led at least one equity round; the number is equity rounds taken part in.
Related companies shared investors
Multiverse ComputingAI Infra · $785M in 2025–2026Shared: Columbus Venture PartnersHighLifeHealth · $90M in 2025–2026Shared: Mérieux Equity PartnersQuoblyDeep Tech · $133M in 2025–2026Shared: BpifranceEntrixEnergy · $49.9M in 2025–2026Shared: KorysMistral AIAI Labs · $5.5B in 2025–2026Shared: BpifranceAMI LabsAI Labs · $1B in 2025–2026Shared: Bpifrance
Also in the Barcelona hub see on the globe
Figures in USD at the time of each round. See the methodology for how rounds are sourced and verified. Ona Therapeutics and its logo are trademarks of their owners, used here for identification only.
